Skip to main content
JBIO logo

JBIO · Jade Biosciences, Inc.

Track JBIO — free
$20.84 -0.45 (-2.11%) At close · Aug 28
Market Cap
$1.35B
Shares
63.60M

Jade Biosciences, Inc. Earnings Call Transcripts

Quarterly earnings calls for Jade Biosciences, Inc. (JBIO), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Conference
Investor event
2026-04-21
Jade Biosciences, Inc. (JBIO) April 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-10
Jade Biosciences, Inc. (JBIO) Q4 2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q1
2024-05-13
Jade Biosciences, Inc. (JBIO) Q1 2024 Earnings Call
Diluted EPS
$-29.05
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-25
Jade Biosciences, Inc. (JBIO) Q4 2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Jade Biosciences, Inc. (JBIO) Q3 2023 Earnings Call
Diluted EPS
$-24.85
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Jade Biosciences, Inc. (JBIO) Q2 2023 Earnings Call
Diluted EPS
$-26.60
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Jade Biosciences, Inc. (JBIO) Q1 2023 Earnings Call
Diluted EPS
$-23.45
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-29
Jade Biosciences, Inc. (JBIO) Q4 2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Jade Biosciences, Inc. (JBIO) Q3 2022 Earnings Call
Diluted EPS
$-19.60
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-15
Jade Biosciences, Inc. (JBIO) Q2 2022 Earnings Call
Diluted EPS
$-17.15
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-16
Jade Biosciences, Inc. (JBIO) Q1 2022 Earnings Call
Diluted EPS
$-15.75
Audio Transcript Slides 8-K10-Q
Showing 1–11 of 11 earnings calls
Key facts CIK 1798749 CUSIP 008064206 13F (30d) 140 filings 139 filers Visit website Investor relations